CAMP4 Therapeutics Corp. (CAMP)
4.42
+0.14
(+3.27%)
USD |
NASDAQ |
Jul 07, 16:00
4.42
0.00 (0.00%)
After-Hours: 20:00
CAMP4 Therapeutics Price : 4.42 for July 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 06, 2026 | 4.42 | 4.42 | 4.09 | 4.28 | 162972.0 |
| Jul 02, 2026 | 4.38 | 4.50 | 4.18 | 4.43 | 114975.0 |
| Jul 01, 2026 | 4.37 | 4.54 | 4.17 | 4.34 | 146139.0 |
| Jun 30, 2026 | 4.50 | 4.579 | 4.20 | 4.37 | 215886.0 |
| Jun 29, 2026 | 4.20 | 4.50 | 4.07 | 4.44 | 157264.0 |
| Jun 26, 2026 | 4.03 | 4.31 | 3.82 | 4.20 | 3.406M |
| Jun 25, 2026 | 4.10 | 4.21 | 3.74 | 3.92 | 238784.0 |
| Jun 24, 2026 | 4.40 | 4.60 | 3.98 | 4.03 | 208944.0 |
| Jun 23, 2026 | 4.17 | 4.545 | 4.17 | 4.36 | 110488.0 |
| Jun 22, 2026 | 4.18 | 4.30 | 3.98 | 4.20 | 116116.0 |
| Jun 18, 2026 | 4.29 | 4.450 | 3.92 | 4.13 | 161146.0 |
| Jun 17, 2026 | 4.33 | 4.60 | 4.09 | 4.14 | 197567.0 |
| Jun 16, 2026 | 4.49 | 5.25 | 4.13 | 4.13 | 867459.0 |
| Jun 15, 2026 | 4.19 | 4.235 | 3.95 | 3.96 | 88371.00 |
| Jun 12, 2026 | 4.22 | 4.46 | 4.16 | 4.19 | 41032.00 |
| Jun 11, 2026 | 4.46 | 4.52 | 4.16 | 4.22 | 60245.00 |
| Jun 10, 2026 | 4.11 | 4.735 | 4.01 | 4.34 | 181389.0 |
| Jun 09, 2026 | 4.09 | 4.440 | 4.00 | 4.01 | 60027.00 |
| Jun 08, 2026 | 4.09 | 4.23 | 3.99 | 4.09 | 77822.00 |
| Jun 05, 2026 | 4.24 | 4.46 | 4.00 | 4.11 | 68957.00 |
| Jun 04, 2026 | 4.19 | 4.61 | 4.19 | 4.30 | 61926.00 |
| Jun 03, 2026 | 3.98 | 4.22 | 3.93 | 4.17 | 48448.00 |
| Jun 02, 2026 | 3.99 | 4.175 | 3.90 | 3.98 | 88546.00 |
| Jun 01, 2026 | 4.39 | 4.65 | 3.90 | 4.04 | 81755.00 |
| May 29, 2026 | 4.50 | 4.50 | 4.270 | 4.39 | 50910.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.21 |
| Alnylam Pharmaceuticals, Inc. | 321.40 |
| Anika Therapeutics, Inc. | 15.87 |
| Savara, Inc. | 6.22 |
| Vericel Corp. | 46.95 |
Price Related Metrics
| PS Ratio | 44.17 |
| Price to Book Value | 7.427 |
| Earnings Yield | -51.37% |
| Market Cap | 229.51M |